机构建议关注高景气TMT领域等业绩预喜板块！科创100ETF华夏（588800）最新规模达29.11亿元！

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index fell by 0.49% as of 10:56 AM, with mixed performance among constituent stocks [1] - Among the constituent stocks, Chengda Biology led with a rise of 7.17%, while Sanofi Biopharma fell by 5.61% [1] - As of July 14, 17 companies on the Sci-Tech Innovation Board announced their half-year performance forecasts, with 16 companies expecting profit increases, resulting in a positive forecast ratio of 94.12% [1] Group 2 - Companies expecting a net profit increase of over 100% include 8 firms, while 4 firms expect a profit increase between 50% and 100% [1] - The sectors with significant profit growth include electronics and biomedicine, with 8 and 2 companies respectively showing strong performance [1] - The average increase in share price for high-growth companies on the Sci-Tech Innovation Board this year is 39.15% [1] Group 3 - The A-share market has been performing strongly, driven by the upward trend in U.S. stocks and the performance of technology leaders [2] - The recommendation is to focus on high-growth sectors such as TMT, midstream manufacturing with global competitiveness, and domestic demand sectors [2] - The Sci-Tech 100 ETF (588800) tracks the Sci-Tech Innovation Board 100 Index, with 80% of holdings being companies with a market cap below 20 billion [2]